Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
World Journal of Clinical Cases|October 21, 2020
Role of monoclonal antibody drugs in the treatment of COVID-19Claudio Ucciferri, Jacopo Vecchiet, Katia FalascaFrontiers in Immunology|January 2, 2026
Microbiota and antibiotic exposure in sarcoidosisClaudio Ucciferri, Livia Moffa, Claudio TanaAIDS Reviews|May 24, 2017
Hypertension in HIV: Management and TreatmentClaudio Ucciferri, Katia Falasca, Jacopo VecchietFrontiers in Immunology|February 9, 2026
Correction: Microbiota and antibiotic exposure in sarcoidosisClaudio Ucciferri, Livia Moffa, Claudio TanaHepato-Gastroenterology|December 24, 2011
Optimization of comorbidity therapy to achieve sustained viral response in HCV patientsClaudio Ucciferri, Jacopo Vecchiet, Eligio Pizzigallo, et al.Mediterranean Journal of Hematology and Infectious Diseases|September 12, 2025
From Legacy to Innovation: Pidotimod's Expanding Therapeutic HorizonClaudio Ucciferri, Francesca Chiappini, Jacopo Vecchiet, et al.International Journal of STD & AIDS|March 24, 2025
"Are new lipid lowering agents a good option for achieving lipid goals in people living with HIV? A case report"Raffaele Ferri, Katia Falasca, Jacopo Vecchiet, et al.Current HIV Research|September 1, 2021
It is Not Always COVID-19: Case Report about an Undiagnosed HIV Man with DyspneaMichela Pontolillo, Katia Falasca, Jacopo Vecchiet, et al.Multidisciplinary Respiratory Medicine|October 3, 2025
Efficacy and safety of deflazacort in diabetic subjects infected with SARS-CoV-2Claudio Ucciferri, Alessandro Di Gasbarro, Jacopo Vecchiet, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 19, 2011
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitisPaola Mancino, Katia Falasca, Claudio Ucciferri, et al.Pageof 7